Press Releases

January 14, 2011 Lupin Announces Final FDA Approval for Nabumetone tablets, 500 mg and 750 mg.

January 5, 2011 LUPIN signs strategic agreement with FARMANGUINHOS, Brazil

January 3, 2011 Lupin Settles all Ongoing Litigation with Sunovion over Generic of LUNESTA® (eszopiclone)

November 2, 2010 Lupin Announces Litigation Settlement with Forest for Memantine Tablets

November 2, 2010 Lupin Announces Final FDA Approval for Suprax® (Cefixime) Chewable Tablets

November 1, 2010 Lupin Net Profit up by 34 % in Q2, FY 2010-11 Robust Growth, Strong Profits

October 14, 2010 Lupin announces settlement with Warner Chilcott of Loestrin® 24 Fe and Femcon® Fe Patent Litigations

October 4, 2010 Lupin Announces Final FDA Approval of Generic Hyzaar® and Cozaar®

August 3, 2010 Lupin appoints Paul McGarty as President for Lupin Pharmaceuticals Inc.